Carlo Giannangelo
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Correction to "Novel Scaffold Unlocks Potent Cross-Peptidase and Cross-Species Inhibitors as Promising Antimalarial Agents".
Journal: Journal of medicinal chemistry
Published: March 20, 2026
Novel Scaffold Unlocks Potent Cross-Peptidase and Cross-Species Inhibitors as Promising Antimalarial Agents.
Journal: Journal of medicinal chemistry
Published: January 12, 2026
Validation of solvent proteome profiling for antimalarial drug target deconvolution.
Journal: International journal for parasitology. Drugs and drug resistance
Published: July 30, 2025
Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites.
Journal: Antimicrobial agents and chemotherapy
Published: July 25, 2025
Novel heterospirocyclic antimalarials with activity against artemisinin- and multidrug-resistant P. falciparum malaria.
Journal: International journal for parasitology. Drugs and drug resistance
Published: July 10, 2025
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4.
Journal: Journal of medicinal chemistry
Published: April 14, 2025
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4.
Journal: Journal of medicinal chemistry
Published: August 12, 2024
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity.
Journal: mBio
Published: May 08, 2024
Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action.
Journal: Frontiers in cellular and infection microbiology
Published: October 06, 2023
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.
Journal: Science (New York, N.Y.)
Published: June 02, 2022
Last Updated: 09/26/2026